All studies
AuthorisedTherapeutic use (Phase IV)Interventional

Intrathecal drug delivery systems versus comprehensive medical management for severe cancer pain: a randomized controlled trial

This research study is looking at the best ways to help people living with severe cancer pain that hasn't responded well to usual treatments. It's comparing two main approaches: using special pain pumps that deliver medicine directly into the fluid around the spinal cord (called intrathecal drug delivery systems) versus receiving a wide range of standard medical treatments. The main goal is to see which approach leads to a better quality of life. Researchers will also be checking things like how much pain people feel, their comfort levels, stress, anxiety, and even the cost of care. This is a later-stage study, meaning the treatments involved are already known and approved.

At a glance

Status
Authorised
Phase
Therapeutic use (Phase IV)
Sponsor
Vrije Universiteit Brussel
Enrolment target
72
Start
04 Mar 2026

What is this study about?

This research study is about finding the best ways to help people who have severe cancer pain that hasn't been relieved by other treatments. We know that living with constant, severe pain can really affect daily life, so this study aims to compare two main methods for managing it.

The first method involves what's called an "intrathecal drug delivery system." This is a small pump that is placed into your body, which then delivers pain medicine directly into the fluid that surrounds your spinal cord. This allows the medicine to work very effectively on the pain. The second method is called "comprehensive medical management," which means you would receive a wide range of standard medical treatments and support for your pain, guided by your doctors.

The main thing researchers want to find out is which of these approaches leads to a better overall quality of life for patients. They'll also be looking at how well each method controls pain, how comfortable patients feel, and how it affects things like stress, anxiety, and even the financial side of healthcare. This is a 'Phase IV' study, which means the treatments being looked at are already approved for use, and researchers are now gathering more information on their long-term effects and how they compare in real-world settings.

Key takeaways

  • Compares two ways to treat severe cancer pain: special pain pumps vs. standard medical care.
  • Aims to improve quality of life for people with challenging pain.
  • Monitors pain, comfort, stress, and emotional well-being.
  • Uses approved medications and treatments.
  • Participation involves questionnaires and regular follow-ups.
  • You can leave the study at any time without affecting your care.

Who may be eligible?

To be considered for this study, you need to be an adult, at least 18 years old. The study is open to both men and women.

The most important health requirement is that you must be experiencing severe cancer pain that hasn't responded well to other types of pain relief you've tried. This means your doctors have likely tried different treatments for your pain, but it's still significantly affecting you.

There might be other specific health conditions or treatments that could affect whether you can join, but these would be discussed with you by the research team and your doctor if you're interested.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 18 years old or older?
  2. Do you have severe cancer pain that hasn't responded to other treatments?
  3. Are you available for regular follow-ups and questionnaires?
  4. Are you comfortable with the idea of potentially receiving different pain treatments?
Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you would be assigned to one of the two treatment groups: either receiving pain medication through a special pump, or continuing with comprehensive medical pain management. The medications being used, such as different forms of morphine, bupivacaine, or ropivacaine, are all approved and commonly used pain relief drugs.

Throughout the study, you'll be asked to complete several questionnaires. These will help researchers understand your quality of life, comfort levels, pain intensity, and how you're feeling emotionally. You might have phone calls each month where researchers will ask about your health, any new medical appointments, changes in your medicine, and any costs related to your healthcare.

Regular check-ups will also be part of your participation, where researchers will monitor your health and any side effects. The study will follow you from when your treatment starts until further notice, and your survival rate will be monitored. The information gathered will help improve care for others in the future.

Potential risks and benefits

Taking part in this study could potentially improve your pain management and overall quality of life by finding a more effective treatment for your severe cancer pain. However, as with any medical treatment, there are potential risks associated with the medications or procedures involved, such as side effects from pain medicines or risks related to the pump insertion, if you are in that group. The research team will carefully monitor you for any side effects or unexpected events. You are always free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • Unverified
    Belgium

Common questions

What does 'severe refractory cancer pain' mean?

It means you have very strong pain from cancer that hasn't gotten much better with the usual pain treatments your doctors have tried.

What is an 'intrathecal drug delivery system'?

It's a small pump placed in your body that sends pain medicine directly into the fluid around your spinal cord for more focused pain relief.

Will I get to choose which treatment I receive?

This is a randomised study, meaning a computer or similar method will decide which treatment group you are in, like flipping a coin for fairness.

What kind of questions will I be asked?

You'll be asked about your pain levels, how you're feeling generally, your comfort, stress, and anxiety, using special questionnaires.

How long will I be in the study?

You will be followed from the start of your treatment until further notice, meaning for an extended period to monitor long-term effects and survival.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.